Taha Keilani

Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol <i>Escherichia coli</i> L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4

Anne Angiolillo, Reuven J. Schore, Meenakshi Devidas et al. · Journal of Clinical Oncology · 2014 · 126 citations · Full text

Improvement of Lipid Abnormalities Associated with Proteinuria Using Fosinopril, an Angiotensin-Converting Enzyme Inhibitor

Taha Keilani, William Schlueter, Murray L. Levin et al. · Annals of Internal Medicine · 1993 · 110 citations

On the mechanism of impaired distal acidification in hyperkalemic renal tubular acidosis

William Schlueter, Taha Keilani, M Hizon et al. · Journal of the American Society of Nephrology · 1992 · 33 citations

Electrolyte Disorder, Renal Function, Electrolyte Disturbance +17

Beneficial Effects of Complement Inhibition With Soluble Complement Receptor 1 (TP10) During Cardiac Surgery

Harold L. Lazar, Taha Keilani, Carmel Fitzgerald et al. · Circulation · 2007 · 29 citations · Full text

A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium

Taha Keilani, Farhad R. Danesh, William Schlueter et al. · American Journal of Kidney Diseases · 1999 · 28 citations

Urological Research, Urology, Renal Function +10